Elizabeth Lihua Elizabeth Budde, MD, PhD¹, Adam J Olszewski, MD², Sarit Assouline, MD³, Izidore S. Lossos, MD⁴, Catherine Diefenbach, MD^5*, Manali Kamdar, MD^6*, Nilanjan Ghosh, MD, PhD⁷, Dipenkumar Modi, MD⁸, Waleed Sabry, MSc, MD, PhD^9*, Seema Naik, MD^10*, Amitkumar Mehta, MD^11*, Shazia K. Nakhoda, MD^12*, Stephen D Smith, MD¹³, Kathleen Dorritie, MD¹⁴, Ting Jia, MD^15*, Song Pham, MSc^16*, Ling-Yuh Huw, PhD^17*, Hao Wu, PhD^17*, Iris To, PharmD^17*, Michael C. Wei, MD, PhD¹⁷ and Julio C. Chavez, MD^18*

¹City of Hope National Medical Center, Duarte, CA
²Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, RI
³Jewish General Hospital, McGill University, Montreal, QC, Canada
⁴University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
⁵Perlmutter Cancer Center at NYU Langone Health, New York, NY
⁶University of Colorado, Aurora, CO
⁷Levine Cancer Institute/Atrium Health, Charlotte, NC
⁸Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁹Saskatoon Cancer Centre, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
¹⁰Penn State Cancer Institute, Hershey, PA
¹¹University of Alabama at Birmingham, Birmingham, AL
¹²Fox Chase Cancer Center, Philadelphia, PA
¹³Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
¹⁴UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA
¹⁵Roche (China) Holding Ltd., Shanghai, China
¹⁶F. Hoffmann-La Roche Ltd., Basel, Switzerland
¹⁷Genentech, Inc., South San Francisco, CA
¹⁸Moffitt Cancer Center, Tampa, FL

Chan Y. Cheah, MBBS^1,2, Sarit Assouline, MD³, Ross Baker, MBBS^4*, Nancy L. Bartlett, MD⁵, Dima El-Sharkawi, MBBS, FRCPath, PhD^6*, Pratyush Giri, MBBS^7*, Matthew Ku, MBBS^8*, Stephen J. Schuster, MD⁹, Matthew Matasar, MD, MS¹⁰, John Radford, MD^11*, Michael C. Wei, MD, PhD^12*, Shen Yin, PhD^12*, Iris To, PharmD^12*, Jiangeng Huang, PhD^12*, Antonia Kwan, MBBS, PhD^12* and Elizabeth Lihua Elizabeth Budde, MD, PhD¹³

¹The University of Western Australia, Perth, Australia
²Linear Clinical Research, Sir Charles Gairdner Hospital, Nedlands, Australia
³Jewish General Hospital, Montreal, QC, Canada
⁴Perth Blood Institute, Murdoch University, Perth, Australia
⁵Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁶The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
⁷Royal Adelaide Hospital, Adelaide, Australia
⁸St Vincent's Hospital, University of Melbourne, Melbourne, Australia
⁹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁰Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹¹Christie NHS Foundation Trust, Manchester, United Kingdom
¹²Genentech, Inc., South San Francisco, CA
¹³City of Hope National Medical Center, Duarte, CA

Trent Wang, DO, MPH¹, Kwang Wooahn, PhD^2*, Manmeet Kaur^3*, Mazyar Shadman, MD, MPH⁴, Alex F. Herrera, MD⁵, Craig S Sauter, MD⁶, Mehdi Hamadani, MD⁷ and Antonio M. Jimenez Jimenez, MD, MSc^8*

¹University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center, Miami Springs, FL
²Medical College of Wisconsin, milwaukee, WI
³Medical College of Wisconsin, Milwaukee, WI
⁴Fred Hutchinson Cancer Center, Seattle, WA
⁵City of Hope, Duarte, CA
⁶Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁷Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
⁸Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL

Eric Durot^1*, Damien Roos-Weil^2*, Adrien Chauchet^3*, Justine Decroocq, MD^4*, Roberta Di Blasi, MD, PhD^5*, Thomas Gastinne, MD^6*, Hedi Bensader^7*, Morgane Cheminant^8*, Caroline Jacquet, MD^9*, Stephanie Guidez^10*, François-Xavier Gros^11*, Emmanuel Bachy, MD, PhD^12*, Pascale Cony-Makhoul, MD^13*, Steven P. Treon, MD, PhD, FRCP¹⁴, Alain Jacques Delmer, MD^15*, Ran Reshef, MD, MSc¹⁶, Steven Le Gouill, MD, PhD¹⁷, Jorge J. Castillo, MD¹⁸ and Roch Houot, MD, PhD^19*

¹CHU Reims, Reims Cedex, France
²Hôpital Pitié-Salpétrière, Paris, FRA
³Besançon University Hospital, Besançon, France
⁴Clinical Hematology Department, Hopital Cochin, APHP, Paris, France, Paris, France
⁵Department of Hematology, Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis, University of Paris, PARIS, France
⁶Hématologie, Hôpital Hôtel Dieu, Nantes Cedex 1, France
⁷CHU de Clermont-Ferrand, Clermont-Ferrand, France
⁸Department of Hematology, Necker Hospital, APHP, Paris, France
⁹CHU de Nancy, Vandoeuvre Les Nancy, FRA
¹⁰CHU de Poitiers, Poitiers, FRA
¹¹Hôpital Du Haut-Lévèque, CHU de Bordeaux, Pessac, FRA
¹²Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
¹³Department of Hematology, Annecy-Genevois Hospital Centre, Pringy, France
¹⁴Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
¹⁵Hôpital Robert Debré CHU de Reims, Reims Cedex, -, FRA
¹⁶Columbia University Medical Center, New York, NY
¹⁷Hematology Department, Institut Curie, Paris, France
¹⁸Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
¹⁹Centre Hospitalier Universitaire Rennes, Université de Rennes, Rennes Cedex, FRA

Peter A Riedell, MD¹, Connor Grady, MPH^2*, Loretta J. Nastoupil, MD³, Alejandro Luna, MD, PhD^4,5*, Nausheen Ahmed, MD⁶, Richard T Maziarz, MD⁷, Marie Hu, MD⁸, Jamie Brower, MS^9*, Wei-Ting Hwang, PhD^10*, Stephen J Schuster, MD¹¹, Andy Chen, MD, PhD⁷, Olalekan O. Oluwole, MBBS¹², Veronika Bachanova, MD, PhD⁸, Joseph P McGuirk, DO⁶, Miguel-Angel Perales, MD^13,14, Michael R. Bishop, MD¹ and David L. Porter, MD⁹

¹David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
²Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
³MD Anderson Cancer Center, Houston, TX
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Hospital Universitario Ramon y Cajal, Department of Adult Bone Marrow Transplantation, Madrid, Spain
⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁷Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁸Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
⁹Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹⁰Department of Biostatistics, Epidemiology, and Informatics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
¹¹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹²Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹³Department of Medicine, Weill Cornell Medical College, New York
¹⁴Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Emil Ramsø Kyvsgaard^1,2,3*, Michael Roost Clausen, MD, PhD^4*, Anna Caroline Hasselbalch Riley, MD^1,2*, Carsten Utoft Niemann, MD, PhD^1,5*, Kirsten Grønbæk, MD, DMSc^1,3,5, Martin Hutchings, MD PhD^1,2* and Simon Husby, MD, PhD^1,2,3*

¹Department of Hematology, Rigshospitalet, Copenhagen, Denmark
²Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark
³Grønbæk Group, Biotech Research and Innovation Centre, BRIC, University of Copenhagen, Copenhagen, Denmark
⁴Department of Hematology, Vejle Hospital, Vejle, Denmark
⁵Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark